SEC Form 4 · accession 0001628280-26-056653
AbCellera Biologics Inc. · ABCL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael R Hayden
Director
Period of report
Aug 11, 2026
Accepted (ET)
Aug 13, 2026 · 3:01 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001703057
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1,F2 | Aug 11, 2026 | G | 50,000 | $0.00 | D | 1,273,397 | I | See footnote |
| Common Shares | holding | — | — | — | 118,245 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction represents a charitable donation of 50,000 common shares made by Genworks 2 Consulting, Inc. on August 11, 2026.
- F2These shares are held by Genworks 2 Consulting, Inc. The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2 Consulting, Inc. The reporting person disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest, if any, therein.